The timing of when human biological clocks first start ticking has profound implications for lifelong health patterns, from sleep disorders to metabolic disease susceptibility. Understanding this developmental window could reshape prenatal care and infant health outcomes. Mouse embryo studies reveal that fetal circadian rhythms emerge as early as mid-pregnancy and gradually align with maternal cycles through a sophisticated hormonal communication system. Researchers tracked the PERIOD2 protein, a core circadian clock component, in developing mouse fetuses from embryonic day 8.5 to 17.5 using bioluminescence imaging. Initially, fetal circadian peaks occurred at random times, but by day 15.5, they consistently aligned with early nighttime patterns. Crucially, pregnancies lacking detectable fetal circadian variation showed higher failure rates, suggesting rhythmic development may be essential for successful pregnancy outcomes. The synchronization mechanism appears to involve maternal glucocorticoids—stress hormones that cross the placental barrier. When researchers injected pregnant mice with corticosterone at specific times, they could deliberately shift fetal circadian timing. Conversely, blocking glucocorticoid signaling disrupted mother-fetus synchronization. This discovery challenges the assumption that circadian rhythms only begin functioning after birth when infants are first exposed to light-dark cycles. Instead, it suggests maternal lifestyle patterns—stress levels, sleep timing, eating schedules—may be programming fetal biological clocks weeks before delivery. For human applications, this raises questions about optimal prenatal care timing, maternal stress management, and whether circadian disruption during pregnancy could predispose children to metabolic or sleep disorders. The research remains preliminary, conducted only in mice, but it opens new avenues for understanding how maternal health behaviors influence lifelong circadian health in offspring.